81

Zylox-Tonbridge Medical Technology Co LtdFRA Zylox-Tonbridge Medical Stock Report

Last reporting period 30 Jun, 2023

Updated 12 Nov, 2024

Last price

Market cap $B

0.488

Micro

Exchange

XFRA - Deutsche Boerse AG

818.F Stock Analysis

81

Uncovered

Zylox-Tonbridge Medical Technology Co Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0.488

Dividend yield

Shares outstanding

329.9 B

Zylox-Tonbridge Medical Technology Co., Ltd. engages in the production and sales of neurovascular and peripheral-vascular interventional surgical devices. The company is headquartered in Hangzhou, Zhejiang and currently employs 594 full-time employees. The company went IPO on 2021-07-05. The firm's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The firm's products are sold to domestic and foreign markets.

View Section: Eyestock Rating